黄芪甲苷通过PPARγ抑制Th1、Th17分化改善自身免疫性脑脊髓炎

被引:22
作者
梁莉 [1 ]
鲁佑瑜 [1 ]
劳小平 [2 ]
张兆 [3 ]
林椿人 [4 ]
张炜志 [4 ]
机构
[1] 上海市第一人民医院嘉定分院上海市嘉定区江桥医院神经内科
[2] 广西医科大学第九附属医院北海市人民医院神经内科
[3] 广西南宁市第一人民医院神经内科
[4] 广西医科大学第十附属医院钦州市第一人民医院神经内科
关键词
黄芪甲苷; 小鼠实验性自身免疫性脑脊髓炎; CD4+T细胞; PPARγ; Th1/Th17分化;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
100806 [中药药理学];
摘要
目的探讨黄芪甲苷实验性自身免疫性脑脊髓炎(EAE)治疗作用及其机制。方法采用髓磷脂少突胶质细胞糖蛋白35-55(MOG35-55)免疫C57BL/6小鼠构建EAE模型,随机分为对照(PBS)组与黄芪甲苷(AS-IV)组(100 mg/kg)。免疫前3天连续腹腔注射黄芪甲苷,免疫后隔天注射,持续观察小鼠发病情况。取脊髓切片HE染色观察炎性细胞浸润,LFB染色评估脊髓髓鞘脱失,流式细胞数检测CD4+T细胞向Th1与Th17细胞分化比例。提取正常小鼠脾脏中CD4+T细胞,在细胞因子作用下诱导分化,加入不同剂量黄芪甲苷与PPARγ抑制剂T0070907探究其对CD4+T细胞分化的影响。采用Western blot检测PPARγ、NF-κB与NLRP3表达。结果与对照组相比,AS-IV组EAE小鼠发病率降低,发病时间延迟,且骨髓炎性细胞浸润减少,髓鞘脱失抑制,脾脏与脊髓中Th1与Th17细胞表型的含量减少。体外实验中,黄芪甲苷剂量依赖性减少了CD4+T细胞向Th1与Th17细胞表型分化,然而,T0070907逆转了黄芪甲苷的抑制作用。与此同时,无论是在体内还是体外实验中,黄芪甲苷有效增加了PPARγ表达,减少了p-NF-κB与NLRP3表达水平。结论黄芪甲苷通过激活PPARγ,介导NF-κB信号通路抑制,减少CD4+T细胞向Th1与Th17细胞分化,减轻小鼠EAE症状。
引用
收藏
页码:954 / 961
页数:8
相关论文
共 17 条
[2]
Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models [J].
Lecca, Daniela ;
Janda, Elzbieta ;
Mulas, Giovanna ;
Diana, Andrea ;
Martino, Concetta ;
Angius, Fabrizio ;
Spolitu, Stefano ;
Casu, Maria Antonietta ;
Simbula, Gabriella ;
Boi, Laura ;
Batetta, Barbara ;
Spiga, Saturnino ;
Carta, Anna R. .
BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (16) :3298-3314
[3]
Astragaloside IV attenuates orbital inflammation in Graves' orbitopathy through suppression of autophagy [J].
Li, Hong ;
Zhang, Yali ;
Min, Jie ;
Gao, Long ;
Zhang, Ren ;
Yang, Yucheng .
INFLAMMATION RESEARCH, 2018, 67 (02) :117-127
[4]
GPR65 inhibits experimental autoimmune encephalomyelitis through CD4+ T cell independent mechanisms that include effects on iNKT cells [J].
Wirasinha, Rushika C. ;
Vijayan, Dipti ;
Smith, Nicola J. ;
Parnell, Grant P. ;
Swarbrick, Alexander ;
Brink, Robert ;
King, Cecile ;
Stewart, Graeme ;
Booth, David R. ;
Batten, Marcel .
IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (02) :128-136
[5]
Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming [J].
Fernandez, Miriam ;
Monsalve, Eva M. ;
Lopez-Lopez, Susana ;
Ruiz-Garcia, Almudena ;
Mellado, Susana ;
Caminos, Elena ;
Javier Garcia-Ramirez, Jose ;
Laborda, Jorge ;
Tranque, Pedro ;
Diaz-Guerra, Maria Jose M. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (12) :2090-2100
[6]
Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption [J].
Souza, Priscila S. ;
Goncalves, Elaine D. ;
Pedroso, Giulia S. ;
Farias, Hemelin R. ;
Junqueira, Stella C. ;
Marcon, Rodrigo ;
Tuon, Talita ;
Cola, Maira ;
Silveira, Paulo C. L. ;
Santos, Adair R. ;
Calixto, Joao B. ;
Souza, Claudio T. ;
de Pinho, Ricardo A. ;
Dutra, Rafael C. .
MOLECULAR NEUROBIOLOGY, 2017, 54 (06) :4723-4737
[7]
Research review on the pharmacological effects of astragaloside IV [J].
Li, Lei ;
Hou, Xiaojiao ;
Xu, Rongfang ;
Liu, Chang ;
Tu, Menbayaer .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (01) :17-36
[8]
MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation [J].
Liu, Wen ;
Guo, Wenjie ;
Hang, Nan ;
Yang, Yuanyuan ;
Wu, Xuefeng ;
Shen, Yan ;
Cao, Jingsong ;
Sun, Yang ;
Xu, Qiang .
ONCOTARGET, 2016, 7 (21) :30536-30549
[9]
Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis [J].
Yang, C. ;
He, D. ;
Yin, C. ;
Tan, J. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 82 (04) :345-351
[10]
Th1 and Th17 Cytokines Drive Inflammation in Takayasu Arteritis [J].
Saadoun, D. ;
Garrido, M. ;
Comarmond, C. ;
Desbois, A. C. ;
Domont, F. ;
Savey, L. ;
Terrier, B. ;
Geri, G. ;
Rosenzwajg, M. ;
Klatzmann, D. ;
Fourret, P. ;
Cluzel, P. ;
Chiche, L. ;
Gaudric, J. ;
Koskas, F. ;
Cacoub, P. .
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (05) :1353-1360